The world is being quietly rearranged by people who write very long documents.


The title they went with Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Fungal Nucleic Acids Directly in Respiratory Specimens Noisy translates that to

US health regulators will fast-track new tests for fungal infections in lungs


The US Food and Drug Administration (FDA) has created a new, faster approval path for devices that detect fungal infections directly from lung samples. This means new diagnostic tests for serious lung infections can reach patients more quickly.
Before this, new tests for fungal infections had to go through a longer, more expensive approval process. This change means companies can now get these devices to market faster and with less regulatory burden. It should lead to more innovation and availability of these critical diagnostic tools.
Watch for an increase in the number of new fungal nucleic acid detection devices receiving FDA approval in the next 12-24 months.

If you insist
Read the original →